Dermata Therapeutics Ownership | Who Owns Dermata Therapeutics?
Dermata Therapeutics Ownership Summary
Dermata Therapeutics is owned by 38.16% institutional investors, and 61.84% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.44% of its assets in Dermata Therapeutics shares.
DRMA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Dermata Therapeutics | 38.16% | - | 61.84% |
Sector | Healthcare Stocks | 47.31% | 8.01% | 44.69% |
Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2022 | 11 | 22.22% | 292,762 | 48.44% | 38 | 5.77% | 7 | 40.00% | 1 | - |
Sep 30, 2022 | 9 | -10.00% | 197,232 | -76.89% | 25 | 0.17% | 5 | -37.50% | 1 | - |
Jun 30, 2022 | 10 | 42.86% | 853,449 | 1074.14% | 121 | 62.91% | 8 | 100.00% | - | -100.00% |
Mar 31, 2022 | 7 | -30.00% | 72,687 | -44.17% | 13 | 0.59% | 4 | -55.56% | 1 | - |
Dec 31, 2021 | 10 | 25.00% | 130,204 | -50.67% | 48 | 0.50% | 9 | 28.57% | 1 | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Extended Market Index | 6.71K | 0.44% | 1.86K |
Fidelity Nasdaq Composite Index | 66.00 | 0.00% | - |
SSgA U.S. Extended Market Index Class I | 68.00 | 0.00% | - |
State St US Extended Mkt Indx NL Cl C | 4.00 | 0.00% | - |
SSgA U.S. Total Market Index Strategy | 2.00 | 0.00% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 23, 2021 | PROEHL GERALD T | President, CEO and Chairman | Buy | $48.00K |
Aug 17, 2021 | HALE DAVID F | - | Buy | $250.00K |
Aug 16, 2021 | PROEHL GERALD T | President, CEO and Chairman | Buy | $1000.00K |
Aug 16, 2021 | PROEHL GERALD T | President, CEO and Chairman | Buy | $1000.00K |
Aug 16, 2021 | PROEHL GERALD T | President, CEO and Chairman | Buy | $49.63K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q1 | - | - |
2023 Q1 | - | - |
2022 Q4 | - | - |
2022 Q3 | - | - |
2022 Q2 | - | - |
DRMA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools